VALIANT LABORATORIES
Back to All Ratios
|
VALIANT LABORATORIES Last 5 Year EBIT Growth History
[Consolidated]
Mar2024 | Mar2023 | |
---|---|---|
EBIT Growth(%) | -101.80 | - |
What is the latest EBIT Growth ratio of VALIANT LABORATORIES ?
Year | EBIT Growth |
---|---|
Mar2024 | -101.80 |
Mar2023 | - |
How is EBIT Growth of VALIANT LABORATORIES Trending?
Years | EBIT Growth | % Change | |
---|---|---|---|
Mar2024 | -101.8 | 0 | |
Mar2023 | 0 | - |
Other Financial Ratios of VALIANT LABORATORIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of VALIANT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VALIANT LABORATORIES | ₹495.2 Cr | -0.8% | 0.9% | -17.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹185,609.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics |
VALIANT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VALIANT LABORATORIES | -0.8% |
0.9% |
-17.6% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses